Superworth

Thermo Fisher Scientific forward PE TMO

Share price divided by analysts' consensus earnings for the next twelve months, since 1994.

Today, Oct 23, 2026
25.0×
10-year median
22.5×
Against its 10-year history
71st
percentile: 0 is its lowest day, 100 its highest
10-year range
16.0× to 31.8×
Peer median
27.8×

Thermo Fisher Scientific's forward PE is 25.0× as of Oct 23, 2026.

That is above its ten-year median of 22.5×, higher than on 71% of days in the last ten years.

Over that time it ranged from 16.0× in Dec 2016 to 31.8× in Dec 2021.

The median for 9 diagnostics and research stocks of a similar size is 27.8×.

Forward PE over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far25.0×17.3×26.3×
202524.4×17.6×26.8×
202424.2×23.6×28.6×
202325.6×20.8×27.9×
202225.9×23.3×29.5×
202131.8×20.5×31.8×
202019.9×16.1×25.0×
201924.1×18.9×24.6×
201819.0×18.4×22.4×
201719.4×16.3×20.4×
201616.0×15.3×18.8×
201518.2×15.9×19.0×
201418.3×16.4×20.1×
201319.2×13.2×19.2×
201212.7×10.6×13.0×
201110.2×10.0×15.4×
201014.5×12.0×16.2×
200914.6×11.4×15.0×
200811.5×10.4×21.6×
200720.6×18.8×23.3×

Against its peers

Companies in Medical - Diagnostics & Research nearest Thermo Fisher Scientific's size, closest first, today.

CompanyForward PE
TMOThermo Fisher Scientific25.0×
DHRDanaher25.4×
AAgilent Technologies26.4×
IQVIQVIA20.5×
WATWaters29.2×
IDXXIDEXX Laboratories35.9×
ILMNIllumina47.2×
MTDMettler-Toledo International33.9×
DGXQuest Diagnosticsn/m
LHLabcorp17.4×
Peer median27.8×

Where Thermo Fisher Scientific ranks

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Thermo Fisher Scientific

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.